BASILEA PHARMACEUTICA AG ALLSCHWIL CHF1 (REGD) financial statements, including revenue, expenses, profit, and loss

The total revenue of 0QNA for the last semiannual is 76.29 M CHF, and it's 4.90% higher compared to the previous semiannual. The net income of H1 24 is 20.74 M CHF.